CN1454592A - Medical use of andrographolide and its derivatives - Google Patents
Medical use of andrographolide and its derivatives Download PDFInfo
- Publication number
- CN1454592A CN1454592A CN 03129127 CN03129127A CN1454592A CN 1454592 A CN1454592 A CN 1454592A CN 03129127 CN03129127 CN 03129127 CN 03129127 A CN03129127 A CN 03129127A CN 1454592 A CN1454592 A CN 1454592A
- Authority
- CN
- China
- Prior art keywords
- andrographolide
- virus
- herba andrographis
- sars
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention refers to a new use of andrographolid-construction diterpene compound and the use of its derivatives in medicine. The diterpene compound has the remarkable action of resisting SARS caused by coronary virus, and can be used in the medicine to cure and prevent the diseases caused by the SARS virus.
Description
Technical field
The present invention relates to the purposes of the diterpene-kind compound in the medical herbs Herba Andrographis.The medical usage that more specifically refers to andrographolide and derivant, particularly its anti-coronavirus activity can be used in the medicine of prevention, treatment SARS virus disease.
Background technology
Herba Andrographis is a kind of medical herbs, it is documented that it has multiple medical usage:
(1) be used for affection due to external wind and heat, epidemic febrile disease from the beginning of, lung-heat cough with asthma, lung abscess vomiting pus, laryngopharynx swelling and pain.This product bitter cold is fallen and is let out, heat-clearing and toxic substances removing, and kind lung heat clearing fire is so the disease that all lung lung-fire cause all can be used.Control affection due to external wind and heat or epidemic febrile disease from the beginning of, fever and headache, normal and Flos Lonicerae, Fructus Forsythiae, Herba Menthae are equal to usefulness.Control cough due to lung-heat's asthma, normal and Radix Scutellariae, Cortex Mori, Cortex Lycii share; Control lung abscess and cough vomiting pus expectorant, many and medicines such as Herba Houttuyniae, Radix Platycodonis, Semen Benincasae are with usefulness; Control laryngopharynx swelling and pain, normal and medicines such as Radix Scrophulariae, Fructus Arctii, Radix Isatidis are with usefulness.
(2) be used for damp-heat dysentery, the puckery pain of pyretic stranguria, eczema pruritus.This product is bitter dry cold in nature, the effect of heat-clearing and toxic substances removing dampness is arranged, so all damp and hot all diseases all can be used.It is damp and hot to control gastrointestinal, and foot is had loose bowels bitterly, dysentery pus and blood person, can be singly with or be equal to usefulness with Herba Portulacae, Rhizoma Coptidis, control damp-heat in the urinary bladder, drench the puckery pain of drop, manyly share with medicines such as Semen Plantaginis, Rhizoma Imperatae, Cortex Phellodendris, control the eczema pruritus, can this product be last, the glycerol accent is coated with.
(3) be used for carbuncle sore tumefacting virus, snake bite and insect sting.Wood product heat-clearing and toxic substances removing, dampness is subsided a swelling, so availablely control all diseases of damp and hot fire-toxin.Control carbuncle sore tumefacting virus, snake bite and insect sting can singly be used, or joins decoctions such as Flos Lonicerae, Flos Chrysanthemi Indici, Rhizoma Paridis, and mashes external application with bright product, and the effect of removing toxic substances and promoting subsidence of swelling is all arranged.
Andrographolide is to separate a kind of diterpene-kind compound that obtains from medical herbs Herba Andrographis.This chemical compound has heat-clearing and toxic substances removing, removing heat from blood, detumescence.Be used for cold, fever, laryngopharynx swelling and pain, aphtha of the mouth and tongue, pertussis chronic cough, dysentery, the puckery pain of pyretic stranguria, carbuncle skin infection, venom.
The SARS that is caused by coronavirus is the human a kind of disease that runs into recently, has very strong infectiousness, people's health and lives is caused very big threat, and had a strong impact on people's live and work order in worldwide.The present invention carries out pharmacological screening to extracting the andrographolide and the derivant thereof that obtain in the Herba Andrographis, proves that it has the anti-coronavirus activity, is expected to help to prevent and treat the SARS that coronavirus causes, and will produce the huge social benefit.
Summary of the invention
The object of the invention is to provide andrographolide and derivant thereof to use in preparation prevention, the anti-SARS disease medicament of treatment.
The present invention implements like this:
The Herba Andrographis diterpene-kind compound can obtain or natural Herba Andrographis diterpene is carried out chemical derivatization to obtain by the conventional chemical extracting method from medical herbs Herba Andrographis;
Chemical structural formula is as follows:
Wherein, R
1, R
2, R
3=H, acyl group and sodium sulfite addition product that organic acid and mineral acid form.
The hydroxyl of andrographolide forms its acyl group in the presence of organic acid or mineral acid, also can form addition product in the presence of sodium sulfite.
The effect test of the anti-SARS virus of andrographolide is as follows:
TestDate: 2003-5-31
Test event: medicine anti-SARS virus screening active ingredients (virus-cellular level model)
Test philosophy: as virus host cell (permissive cell), specimen is resisted the effect of virus infected cell with the Vero-E6 cell, and detecting index is cytopathy reaction (CPE) and infection cell protective rate.
Test material and method:
1. specimen: andrographolide
2. The National Center for Drug Screening's sample number:
3. Strain: BJ-01
4. sample treatment: sample is dissolved in culture fluid or DMSO, is made into suitable initial concentration, 3 times of dilutions, 6 dilution factors.
5. method of testing: the Vero-E6 cell inoculation in 96 well culture plates, is put 37 ℃, 5%CO
2Cultivate, add the sample and the SARS virus of different diluted concentrations respectively, establish virus control, cell contrast and sample contrast.Observed result under the every day mirror, record CPE, and measure OD value with dimethyl diaminophenazine chloride dyeing, carries out the calculating and the evaluation of sample anti-SARS virus active function with reference to contrasting.Test result:
Concentration (ug/ml) CPE infection cell protective rate
100 - 10.83
33.3 - 3.65
11.1 - 2.30
3.7 + 1.37
1.23 ++ 1.37
0.41 +++ 0.98
Cytopathy political reform (CPE): represent cytopathy degree,＜25%+, 25%～50%++, 50%～75+++,＞75%++++ with plus sige.
The infection cell protective rate: by comparing the OD value of virus control, cell contrast and sample contrast, calculation sample is to the protection activity of virus infected cell, and protective rate＞1.5 multiplying powers tentatively is considered to sample virus infected cell is had the certain protection activity.
*Sample cell toxicity: if the cytotoxicity of sample and cell contrast ratio＞50% o'clock are not that CPE estimates and protective rate calculating.
Conclusion: institute's sample product andrographolide has protection cell resistance SARS virus infection activity.
The specific embodiment
The extracting method of andrographolide: get Herba Andrographis stem and leaf coarse powder 300 grams, divide merceration 2 times with 1500 milliliters of ethanol, each 24 hours, merge twice leachate in 5000 milliliters of round-bottomed flasks, add 25 gram active carbon reflux decolours 30 minutes, sucking filtration while hot reclaims ethanol to 100 milliliter, is transferred in the conical flask, slowly add about 30 milliliters of water, place crystallize, sucking filtration, a little washing of water.Filter cake adds 8 times and measures ethanol, and heating makes dissolving, and add the active carbon that is about liquor capacity 1% again and refluxed 30 minutes, sucking filtration, filtrate is placed crystallize, gets white andrographolide crude product.The andrographolide crude product is added the jolting of 5 times of amount chloroforms, and merceration was placed 1 hour, filtered.With handling twice again with method, insoluble part is an andrographolide.This insoluble part after drying at room temperature, is added 10 (W/W) again and doubly measures ethanol, the reflux dissolving, the active carbon that is incorporated as liquor capacity 1% after cold slightly continues to reflux about 30 minutes, sucking filtration, and filtrate recycling ethanol is to half amount, put the cold analysis crystalline substance, sucking filtration must be made with extra care andrographolide.
Andrographolide sodium sulfite addition product preparation method: andrographolide 0.5 gram adds 12 milliliters of ethanol, heating for dissolving.Get 3 milliliters of 1mol/L sodium sulfite solutions, add the about 4 milliliters of mixing of 2% sulphuric acid (pH of mixed liquor should be between the 5.6-5.9), add 5 milliliters in water.Andrographolide ethanol liquid is fallen in the sulfuric acid solution as sodium sulfite, and jolting (pH of mixed liquor should be 8) is after the reflux 30 minutes (color should not flavescence), add 2% sulphuric acid and transfer pH, reclaim ethanol, place little separatory funnel to there not being the ethanol flavor to neutral, with chloroform extraction 3 times, each about 8 milliliters, divide water-yielding stratum, be concentrated into the 1-2 milliliter, add the dissolving of ethanol 8-10 milliliter, filter, decompression filtrate recycling ethanol is to doing, vacuum is taken out pine, gets white andrographolide sodium sulfite addition product.
Andrographolide anti-SARS virus active same as above.
Claims (3)
1, a kind of following andrographolide and derivant of being extracted by Chinese medicine Herba Andrographis thereof of structure has the anti-SARS virus activity
2, andrographolide and the derivant of being extracted by Chinese medicine Herba Andrographis thereof according to claim 1 is characterized in that using in preparation prevention, treatment SARS virus cause the medicine of disease.
3, andrographolide and the derivant of being extracted by Chinese medicine Herba Andrographis thereof according to claim 2 is characterized in that using in preparation prevention, treatment severe acute respiratory syndrome medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031291279A CN1165302C (en) | 2003-06-06 | 2003-06-06 | Medical use of andrographolide and its derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031291279A CN1165302C (en) | 2003-06-06 | 2003-06-06 | Medical use of andrographolide and its derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1454592A true CN1454592A (en) | 2003-11-12 |
| CN1165302C CN1165302C (en) | 2004-09-08 |
Family
ID=29260418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031291279A Expired - Fee Related CN1165302C (en) | 2003-06-06 | 2003-06-06 | Medical use of andrographolide and its derivatives |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1165302C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1939420B (en) * | 2005-09-26 | 2012-02-22 | 山东轩竹医药科技有限公司 | Antibacterial and antiviral medicinal composition and its preparation |
| CN101742999B (en) * | 2007-05-31 | 2013-01-09 | 三得利控股株式会社 | Anti-fatigue agent and oral composition each comprising and rographolide as active ingredient |
| CN114246859A (en) * | 2020-09-21 | 2022-03-29 | 北京化工大学 | Application of andrographolide in preparing product for treating coronavirus infection |
-
2003
- 2003-06-06 CN CNB031291279A patent/CN1165302C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1939420B (en) * | 2005-09-26 | 2012-02-22 | 山东轩竹医药科技有限公司 | Antibacterial and antiviral medicinal composition and its preparation |
| CN101742999B (en) * | 2007-05-31 | 2013-01-09 | 三得利控股株式会社 | Anti-fatigue agent and oral composition each comprising and rographolide as active ingredient |
| CN114246859A (en) * | 2020-09-21 | 2022-03-29 | 北京化工大学 | Application of andrographolide in preparing product for treating coronavirus infection |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1165302C (en) | 2004-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1844133A (en) | Process for preparing high purity mangiferin | |
| CN100457139C (en) | Method for preparing a Shuanhuanglian injection and the component detecting method | |
| CN101032538A (en) | Method of preparing substances extracted from Gynura procumbens (Lour.) Merr. and the application | |
| CN101293012B (en) | Antiviral honeysuckle flower Chinese medicine compound preparation and preparation technique | |
| CN1165302C (en) | Medical use of andrographolide and its derivatives | |
| CN105641465A (en) | Traditional Chinese medicine active part composition for controlling oral cavity or throat discomfort caused by haze and preparing method thereof | |
| CN111671827B (en) | Application of callicarpa nudiflora extract in preparation of ulcerative colitis medicines | |
| CN103816210A (en) | Pueraria lobata extract and application thereof | |
| CN1488300A (en) | Cigarette additive extracted from natural plant, and extracting method and use in cigarette thereof | |
| CN1424098A (en) | Medicines for treating pulmonary tuberculosis | |
| CN100488542C (en) | Chinese medicinal lotion | |
| CN103040939B (en) | Traditional Chinese medicine composition for treating cold, as well as preparation method and application thereof | |
| CN103690805B (en) | A kind of Chinese medicine for the treatment of pseudomembranous enteritis | |
| CN1164267C (en) | Chlorogenic acid and isochlorogenic acid composition and medical use thereof | |
| CN1421240A (en) | Chinese medicine prepn for treating throat diseases and stomatopathy and its prepn process | |
| CN100528170C (en) | Mangiferin preparation and production thereof | |
| CN105412195A (en) | Chrysanthemum stem and leaf refined polysaccharide extract with effect of treating acute colitis and application thereof | |
| CN101066425A (en) | Chinese medicine prepn for treating ungual mycosis | |
| CN104911233B (en) | The extracting method of panaxan a kind of and its application in hypoglycemic drug and food is prepared | |
| CN1171896C (en) | Syringic general saponin extractive and its prepn and medicinal composition | |
| CN1291730C (en) | Chinese medicine for preventing and treating SARS virus | |
| CN1943647A (en) | The method for preparing triterpenic acid extract from the loquat leaves | |
| CN110201020B (en) | Chrysanthemum leaf active extract for preventing and treating fever with cough and inflammation and preparation method and application thereof | |
| CN1267665A (en) | Preparation of notoginseng essence as efficient hemostatic material | |
| CN103655755A (en) | Anti-influenza drug and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040908 Termination date: 20120606 |